Drug development is currently an extremely long, expensive and inefficient process. Findings generated in a lab are often very hard to replicate once translated into animal models or in humans.
A family of pharmacological targets, on which approximately 35% of FDA-approved drugs work, consists of receptors at the surface of cells named “G protein coupled receptors” or GPCRs. These membrane proteins sense a wide variety of signals from outside the cell, from hormones to neurotransmitters, or light and odors, to trigger responses of cells, from immune reactions to muscle contraction.
In a new study, researchers describe the development of a new technological platform that will enhance the accuracy and efficiency of drug discovery related to a large family of important pharmacological targets, i.e., GPCRs, allowing it to obtain information that was previously unattainable.
“The new technological platform are biosensors that allow us to detect the activity of GPCRs in their native cellular context and in real time not only with unprecedented fidelity, but also with relative ease. A novelty of this platform is that it is easy for others to implement and that it has been made readily available through a public repository such as open-source,” explains the first author of the study.
The researchers used molecular engineering to create these biosensors, artificial genes that, once expressed as proteins in cells, could detect the activation of very specific cellular responses in real time. The researchers then showed that these biosensors could be leveraged to characterize how many different natural ligands and synthetic drugs change cell responses when the act on the large GPCR class of receptors.
According to the researchers, the biosensor platform described could accelerate drug development for any disease in which GPCRs are implicated, which is a virtually endless list covering neurodegenerative disorders, cancers, cardiovascular diseases, obesity, or asthma, to name a few.
“For example, the ongoing interest in developing safer opioid or non-opioid analgesics would benefit from the features of the technology described in our work. Similarly, there is tremendous interest in developing orally bioavailable substitutes for the anti-obesity drugs commercialized as Ozempic and Wegovy, which would also benefit from the technology we described,” said the senior author.
The researchers hope the tools developed in this study will transform how the field of pharmacology and drug development approaches the investigation of a large and important class of targets. “Since medicines acting on these targets are already part of everyday life, we see great potential on accelerating the discovery of improved drugs for many different indications, from analgesia to anti-obesity drugs,” added the first author.
https://www.cell.com/cell/abstract/S0092-8674(24)00065-5
Latest News
Protein that helps COVID-19…
By newseditor
Posted 26 Jul
Spinal Muscular Atrophy (SM…
By newseditor
Posted 26 Jul
Link between bowel movement…
By newseditor
Posted 26 Jul
Inhibition of IL-11 signall…
By newseditor
Posted 25 Jul
Brain changes linked to obe…
By newseditor
Posted 25 Jul
Other Top Stories
Targeting fat-tissue hormone may lead to type 2 diabetes treatment
Read more
Liver signals to brain to control sugar intake
Read more
Protein Phosphorylation: A Major Switch Mechanism for Metabolic Reg…
Read more
The Genetics of Pediatric Obesity
Read more
The miRNA Interactome in Metabolic Homeostasis
Read more
Protocols
A systems biology approach…
By newseditor
Posted 24 Jul
quantms: a cloud-based pipe…
By newseditor
Posted 22 Jul
Emerging tools and best pra…
By newseditor
Posted 19 Jul
Directly selecting cell-typ…
By newseditor
Posted 17 Jul
PUFFFIN: an ultra-bright, c…
By newseditor
Posted 16 Jul
Publications
Hepatocyte-intrinsic SMN de…
By newseditor
Posted 26 Jul
Aberrant bowel movement fre…
By newseditor
Posted 26 Jul
A pseudoautosomal glycosyla…
By newseditor
Posted 26 Jul
Microglia protect against a…
By newseditor
Posted 26 Jul
Rigor and reproducibility i…
By newseditor
Posted 26 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar